Fatty Liver: all 1,462 studies
Page 1 of 15. Open to participants first (289), then studies with results posted, then the rest; newest registration first within each.
- Lifestyle, Dietary Patterns, and Cardiometabolic Risk in Metabolic Dysfunction-Associated Steatotic Liver Disease Among People Living With HIVNot yet recruitingNCT07861594
- Ultrasound Biomarkers for Assessing Eligibility and Response to Resmetirom TherapyNot yet recruitingNCT07860814
- Trial to Evaluate ALN-CIDEB in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)Not yet recruitingNCT07854782Phase 3
- Impact of Overt and Subclinical Hypothyroidism on Liver Fibrosis in Patients With MASLDNot yet recruitingNCT07827430
- A Single-Dose Pharmacokinetic Study of HRS-4729 Injection in Healthy Participants and Patients With Renal ImpairmentRecruitingNCT07807059Phase 1
- Dietary Intervention Study on Liver Health in Young AdultsRecruitingNCT07786831Not applicable
- Detecting Liver Fibrosis in Patients At-riskNot yet recruitingNCT07775638
- Metabolic Flux Analysis in Metabolic Dysfunction-Associated Steatotic Liver DiseaseNot yet recruitingNCT07760909Not applicable
- Metabolic Liver Disease in Newly Diagnosed People Living With HIV (MASHIV-TR)RecruitingNCT07737340
- Biomarker Panel for PCOS-Associated Liver Steatosis in Adolescent Girls (COMPASS-pedPCOS)Not yet recruitingNCT07731373
- Pre-hepatectomy Rehabilitation in Obese MASLD-Complicated Living Liver Donors With Mazdutide (PRIME)RecruitingNCT07718126Phase 4
- A Study to Investigate Safety and Efficacy of Efimosfermin Compared With Placebo in Adult Participants With Compensated Cirrhosis Due to Metabolic Dysfunction-associated Steatohepatitis (MASH)RecruitingNCT07704892Phase 3
- A Pivotal Clinical Study to Investigate the Safety and Efficacy of Efimosfermin Compared With Placebo in Adult Participants With Compensated Cirrhosis Due to Metabolic Dysfunction-associated Steatohepatitis (MASH)RecruitingNCT07701993Phase 3
- Taiwan Green Propolis for Blood Lipids and Body Fat in Patients With MASLDRecruitingNCT07692438Not applicable
- Impact of Steatotic Liver Disease Associated With Metabolic Dysfunction (MASLD) on Frailty, Cognition, and Quality of Life. A Gender-sensitive Approach Towards a Comprehensive and Equitable Perspective.RecruitingNCT07652892
- Effects of Peanut Consumption on Adults With Metabolic Associated Fatty Liver DiseaseRecruitingNCT07646197Not applicable
- Association Between Fatty Liver and Inflammatory BiomarkersNot yet recruitingNCT07636915
- Interventional AI-Human Collaboration for Steatotic Liver Disease ScreeningEnrolling by invitationNCT07613827Not applicable
- Impact of Ganoderma Lucidum on NRF2 Levels and Antioxidant Status in Metabolic Asscociated Fatty Liver Disease (GL-MAFLD-NRF2 Study)Enrolling by invitationNCT07564947Not applicable
- Siemens Biomarker Multi-modalityRecruitingNCT07495332Not applicable
- Tesamorelin for Reduction of Liver Fat in Adults With Fatty Liver Disease (Mock Study)RecruitingNCT07481734Phase 2
- Prevalence and Risk Factors of Metabolic-Associated Hepatic Steatosis in Individuals Living With Type 1 DiabetesNot yet recruitingNCT07475962
- Impact of a Probiotic Supplementation With Lifestyle Modification on Liver Steatosis, Fibrosis, and Metabolic Health in Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)RecruitingNCT07400367Not applicable
- Personalized Transcranial Magnetic Stimulation (TMS) for Metabolic Dysfunction and Alcohol-Related Liver DiseaseNot yet recruitingNCT07399600Not applicable
- Effects of Whole Fruit on Blood Sugar in People With Type 2 DiabetesNot yet recruitingNCT07376226Not applicable
- Ultrasound Liver Imaging for Classification of Metabolic Dysfunction-associated Steatotic Liver DiseaseNot yet recruitingNCT07373769
- ENDOCARE-SCREEN: Metabolic Liver Dysfunction Screening StudyNot yet recruitingNCT07336563
- Metabolic Changes Associated With Weight Gain After Treatment of AchalasiaNot yet recruitingNCT07334639
- Long Term Prediction of MASH-related HCC Risk by ProteomicsNot yet recruitingNCT07332611
- Thermoacoustic Method for Estimating Liver Fat FractionRecruitingNCT07321925
- A Clinical Trial of Longqi Jiangzhi Decoction Against Non-alcoholic Fatty Liver DiseaseNot yet recruitingNCT07320456Phase 2
- A Trial to Evaluate the Efficacy, Safety, PK, and PD of HP515 in Non - Alcoholic Fatty Liver Disease ( NASH/MASH )RecruitingNCT07308548Phase 2
- Dietary Glycine Supplementation in Metabolic Dysfunction-associated Steatotic Liver DiseaseNot yet recruitingNCT07285135Not applicable
- Development of a Quantifiable Ultrasound Biomarker for Hepatic SteatosisRecruitingNCT07270601Not applicable
- Using Hydroxychloroquine (HCQ) to Treat SteatohepatitisRecruitingNCT07265297Phase 3
- Diagnosis and Quantification of Hepatic Steatosis Using Near-infrared SpectroscopyNot yet recruitingNCT07254533Not applicable
- Erdosteine in the Treatment of Nonalcoholic Fatty Liver DiseaseRecruitingNCT07242222Phase 1/2
- Cilostazol in the Treatment of Nonalcoholic Fatty Liver DiseaseRecruitingNCT07238985Phase 1/2
- Visceral Adipose Tissue and Liver Changes Associated With Semaglutide in CKDRecruitingNCT07187830
- A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)RecruitingNCT07165028Phase 3
- Evaluation of Non-Invasive Tests for Metabolic Liver DiseaseRecruitingNCT07122700
- Gepaktiv vs UDCA and Ademetionine in MAFLD With HepatomegalyRecruitingNCT07068191Not applicable
- CRISPR-Edited HLA Donor Liver Transplant to Reduce RejectionRecruitingNCT07053488Phase 1/2
- Effect of Sinbiotic With Multispecies Probiotics on Liver Parameters Liver Enzymes, Ultrasound, Elastography and Adipokines in Same Cases) in Patients With Metabolic Associated Steatotic Liver Disease.Not yet recruitingNCT07025980Phase 2
- To Evaluate the Tolerability, Pharmacokinetics, and Pharmacodynamics of IMM-H014 in Patients With MASHNot yet recruitingNCT07016633Phase 1/2
- Fructose is a Metabolic and Inflammatory Pathogenic Factor in Metabolic Dysfunction-associated Steatohepatitis (MASH)RecruitingNCT07013916Not applicable
- Acute Exercise and Endogenous Glucose Production in Type 2 Diabetes: Implications for Glycemic Control and Treatment of Hepatic SteatosisRecruitingNCT06993454Not applicable
- Pioglitazone and Empagliflozin for Fatty Liver Disease in Type 2 DiabetesRecruitingNCT06989723Phase 4
- The COherence of Scatter Identification and Exclusion Algorithm StudyRecruitingNCT06975579
- Optimal Measurement of Spleen Stiffness Among Veterans With Metabolic Dysfunction-Associated Steatotic Liver DiseaseEnrolling by invitationNCT06953830Not applicable
- Improving Diagnostic Safety Through STeatosis Identification, Risk Stratification, and Referral in the EDEnrolling by invitationNCT06944353Not applicable
- Elucidating Hepatic Metabolism in Non-alcoholic Fatty Liver DiseaseEnrolling by invitationNCT06942312
- An Observational Study of Inflammatory Bowel Disease (IBD) Patients With Non-alcoholic Fatty Liver Disease (NAFLD)RecruitingNCT06939569
- Integrating Metabolic and Vascular Sensors to Monitor Cardiometabolic Disorders After Nutrition InterventionsNot yet recruitingNCT06932289Not applicable
- Glucose Disposal Rate as a Metric for Detection of Metabolic Associated Fatty LiverNot yet recruitingNCT06923215
- Validity of Laboratory Biomarkers in Diagnosis of Nonalcoholic Fatty Liver Disease (NAFLD) and It's ConsequencesNot yet recruitingNCT06908122
- Long-term Follow-up to Determine Outcome in Liver Disease (LOVE Study)Not yet recruitingNCT06907563
- Medium-term Effects of a Polyphenol-rich Beverage Based on Red Grape Pomace Extract on Non-alcoholic Fatty Liver Disease, Cardiometabolic Risk Profile and Gut Microbiota in Subjects with Type 2 DiabetesEnrolling by invitationNCT06895018Not applicable
- Multiple Dose Study for a New Medication to Potentially Treat Liver DiseasesRecruitingNCT06891365Phase 1
- OneSTOP (One-Stop Telehealth Obesity Program) for Multidisciplinary Weight Management and Related ComorbiditiesRecruitingNCT06890169Not applicable
- Relationship Between Eating Patterns, Body Composition and the Detection of Fatty Liver in Children and Adolescents With Trisomy 21: LiverTy ProjectEnrolling by invitationNCT06888570
- Effect of Low Valine Diet on Body Weight and Metabolic ParametersRecruitingNCT06883578Not applicable
- Effects of Compound Probiotics-Polygonatum Sibiricum on Liver Health and Metabolism in Middle-aged and Elderly PeopleNot yet recruitingNCT06873412Not applicable
- Development of Microbial Therapeutics for Metabolic-associated Fatty Liver Disease: From Mechanistic Investigations to Clinical TrialsRecruitingNCT06873165Not applicable
- Prevalence of Pancreatic Steatosis in Pancreatic Cystic Neoplasms and Pancreatic AdenocarcinomaRecruitingNCT06867172
- Effect of an Early Time Restricted Eating Mediterranean Diet Compared to Naltrexone/Bupropion on Liver Fibrosis in People With Cardiometabolic Risk Factors in a Hospital Outpatient Clinic (MEDFAST-study)Enrolling by invitationNCT06845345Phase 4
- Stimulating Fat Tissue Storage With Niacin to Reduce Fat Accumulation in the Liver.RecruitingNCT06843148Not applicable
- Prevalence of Non-Alcoholic Fatty Liver Disease in Inflammatory Bowel Disease PatientsRecruitingNCT06814600
- Prognostic Factors for HCC and Liver Transplantation in Patients with MASLD/MASHRecruitingNCT06813508
- Pyramidal Versus Continuous Training Effects on Fatty LiverRecruitingNCT06803108Not applicable
- LivQ-box® Parameters in the Diagnosis of Liver InflammationRecruitingNCT06802731
- Effect of the Combined Application of Cynara Scolymus, Silybum Marianum, Curcuma Longa, and Glycyrrhiza Glabra in Improving Metabolic Associated Fatty Liver Disease : a Randomized Clinical TrialRecruitingNCT06798948Phase 2
- Clinical Correlation Evaluation of the LIVERFASt Test for Diagnosing Important Liver Lesions of Fibrosis and Steatosis Against Magnetic Resonance Elastography (MRE) for Liver Fibrosis and MR-based Assessment of Steatosis, in Adult US Population.Not yet recruitingNCT06797596
- Clinical Classification of MAFLD Based Liver BiopsyNot yet recruitingNCT06795646
- The Efficacy and Safety of Chiglitazar in Patients with MAFLD-related CirrhosisNot yet recruitingNCT06773221Not applicable
- Characterization and Management of Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD)Not yet recruitingNCT06764056Not applicable
- Fatty Liver and Pancreatic SteatosisNot yet recruitingNCT06757348
- The Role of Sugars in Fat Accumulation in the LiverRecruitingNCT06751862Not applicable
- Effect of High Protein Diet on Hepatic Steatosis in Patients With MAFLDNot yet recruitingNCT06749704Not applicable
- Fasted Exercise Training in Type 1 Diabetes (FED-T1D)RecruitingNCT06748963Not applicable
- Efficacy of Sodium Glucose Cotransporter 2 Inhibitors on Non-Alcoholic Fatty Liver DiseaseNot yet recruitingNCT06739486
- Thyroid Dysfunction and Its Association With Metabolic Dysfunction-Associated Fatty Liver DiseaseRecruitingNCT06739330
- Feasibility Study of Deep Learning-based MDixon Quant for Quantitative Assessment of Chemotherapy-induced Fatty LiverRecruitingNCT06735118Not applicable
- Walking Program in Fatty Liver Children With PhenylketonuriaRecruitingNCT06718842Not applicable
- The Effects of Tai Chi on Metabolic Dysfunction-associated Fatty Liver Disease in Middle-Aged and Older AdultsRecruitingNCT06717828Not applicable
- Establishment of Precise Histological Evaluation Criteria for NASH Fibrosis ReversalRecruitingNCT06707129
- Quantitative Ultrasound to Assess Steatotic Liver Disease in ChildrenRecruitingNCT06706856
- Effects of TOTUM-448 on Liver Fat Content, Cardiometabolic Risk Factors and Gut Microbiota Among Participants with MASLDRecruitingNCT06704321Not applicable
- A Phase 1b Study of QX1206 in T2DM Patients With NAFLDRecruitingNCT06694935Phase 1
- Osaka Cardiometabolic Epidemiological Study: Ohtori Study Part 2RecruitingNCT06694012
- Metabolic Associated Fatty Liver Disease in Patients With Chronic Glomerular DiseaseNot yet recruitingNCT06691529
- Obeticholic Acid Among Chronic HBV Patients with Hepatic Steatosis : Clinical and Portal Doppler OutcomesNot yet recruitingNCT06691412Phase 3
- Effect of Alternate Day Fasting Over Standard Medical Management Alone to Reverse Non-alcoholic Steatohepatitis.RecruitingNCT06676813Not applicable
- Evaluation of a New Ultrasound System for the Non-invasive Assessment of Liver Steatosis in MASLD/MASH PatientsRecruitingNCT06661655Not applicable
- A Study to Identify the Risk of Non-alcoholic Fatty Liver Disease (NAFLD) in Patients With Type 2 Diabetes in Clinical Practice and to Evaluate the Clinical Usefulness of Dapagliflozin/Pioglitazone Combination TherapyRecruitingNCT06649162
- Burden Fatty Liver Among Acute Ischemic Cerebral Stroke PatientsNot yet recruitingNCT06628700
- Integrated Phenotyping of the Gut-plAtelet-Liver AXIS in the Progression of Chronic Liver Disease (iGAL-AXIS)Not yet recruitingNCT06623084
- Hyperbaric Oxygen Therapy for Metabolic Dysfunction-associated Steatotic Liver DiseasesRecruitingNCT06619808Not applicable
- Quantitative CT Imaging Parameters for Assessing Hepatic Steatosis in CHBNot yet recruitingNCT06616103
- A Study to Investigate the Safety and Efficacy of GSK4532990 Compared With Placebo in Adult Participants Aged 18 to 70 Years With Alcohol-related Liver DiseaseRecruitingNCT06613698Phase 2